Patent details
EP2875817 Title: Pharmaceutical formulation comprising amorphous lenalidomide
Basic Information
- Publication number:
- EP2875817
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP131944852
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Pharmaceutical formulation comprising amorphous lenalidomide
- French Title of Invention:
- Formulation pharmaceutique comprenant du lénalidomide amorphe
- German Title of Invention:
- Pharmazeutische Formulierung enthaltend amorphes Lenalidomid
- SPC Number:
Dates
- Filing date:
- 26/11/2013
- Grant date:
- 18/03/2020
- EP Publication Date:
- 27/05/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/03/2020
- EP B1 Publication Date:
- 18/03/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/11/2020
- Expiration date:
- 26/11/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/03/2020
- Name:
- Synthon B.V.
- Address:
- Microweg 22, 6545 CM Nijmegen, Netherlands (NL)
Inventor
1
- Name:
- Keltjens, Rolf
- Address:
- Netherlands (NL)
2
- Name:
- Van Eupen, Jacobus Theodorus Henricus
- Address:
- Netherlands (NL)
3
- Name:
- Murpani, Deepak
- Address:
- Netherlands (NL)
Classification
- IPC classification:
- A61K 9/16; A61K 31/454;
Publication
European Patent Bulletin
- Issue number:
- 202012
- Publication date:
- 18/03/2020
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|